Navigation Links
Tamiflu effective for treatment and prevention of influenza in children 1 year and older
Date:11/15/2007

Tamiflu (oseltamivir) significantly reduces illness severity and duration in children one year and older, particularly if given within 24 hours of symptom onset, according to new data presented at the World Society for Pediatric Infectious Disease (WISPID) meeting in Bangkok 15-18 November. The antiviral Tamiflu was also shown to reduce the incidence of respiratory tract infections, ear infections and antibiotic use. In addition this season smaller child sized Tamiflu (oseltamivir) capsules of 30 mg and 45 mg doses will be available to provide easier and more convenient dosing by parents.

Children tend to be major vectors of influenza as they have limited pre-existing immunity, often spend time in groups and share germs easily. Its reassuring that oseltamivir can be used for the management of influenza in children as young as one year old, commented Dr Keith Reisinger, Primary Physicians Research, Pittsburgh, Philadelphia, USA. There was a particularly severe influenza season in Australia this year which resulted in 6 deaths in children and we are monitoring whether the predominant strain circulating in Australia in 2007 A(H3) will have the same effect in the Northern Hemisphere when influenza strikes.

Tamiflu was shown to reduce influenza severity by almost a third (29%) and illness duration by a quarter (26%) compared to placebo when initiated within 48 hours of onset1. New data presented showed that if taken within 24 hours of symptom onset the influenza severity was halved (52%) and illness duration reduced by a third (34%) compared to placebo2. In addition there was a 55% reduction in severe ear infections (otitis media) in the Tamiflu group compared to placebo if treatment was started within 24 hours2. Tamiflu given as prevention reduced the incidence of secondary influenza infections3 by 55%. In studies Tamiflu was shown to be well tolerated and did not increase the risk for neurophsychiatric adverse events4.

The new low
'/>"/>

Contact: Lucy Rispin
lucy.rispin@ketchum.com
44-207-611-3621
Ketchum
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Gamma globulin effective in treating eye infections caused by adenoviruses
2. UC health news: molecular pathway may predict chemotherapy effectiveness
3. Socioeconomic position associated with effectiveness of HIV drugs
4. New nanoparticle vaccine is more effective but less expensive
5. MIT model could improve some drugs effectiveness
6. Trial seeks genetic fingerprint for predicting drug effectiveness
7. New hope for horse lovers as effective control for killer ragwort is proposed
8. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
9. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
10. Nicotinic receptors may be important targets for treatment of multiple addictions
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... working on innovative energy supply solutions are included in ... Science Foundation program aimed at promoting environmental sustainability. ... a physics professor, were among the 101 scientists and ... for the Sustainable Chemistry, Engineering and Materials, or SusChEM, ...
... A drug currently used to treat intestinal worms ... which untreated can erode the structuresincluding bonethat hold the ... of print in Antimicrobial Agents and Chemotherapy . ... which is a polymicrobial biofilm, off of the root ...
... OLEDs are already used in the displays of smart phones ... with high contrast, but come with a serious drawback: typically, ... the device is actually converted into light. This ratio can ... platinum or iridium to the active material, but these elements ...
Cached Biology News:NSF awards to UT Arlington researchers will fuel sustainable solutions 2Drug may guard against periodontitis, and related chronic diseases 2Novel LEDs pave the way to cheaper displays 2
(Date:5/6/2015)... EDISON, N.J. , May 6, 2015 Bone ... $2M funding round with Hankey Capital, LLC ("Hankey Capital") of ... developing a proprietary protein for use in bone regenerative medicine ... Nell-1) for use with patients undergoing spinal fusion. ... "We are pleased with the completion of this round of ...
(Date:5/6/2015)... Follow us on LinkedIn ... with diameter ranging between 2 to 10 nanometers, ... materials market. The unique electroluminescent, photoluminescent, photo-physical, and ... confinement effect render the nanoparticles versatile and flexible ... technological, and commercial applications. A host of value-added ...
(Date:5/6/2015)... -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of ... Cassian Yee , M.D., Professor, Department of Melanoma ... of Texas MD Anderson Cancer Center joined its scientific ... Immunology, Division of Cancer Medicine, and Director, Solid Tumor ... University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... Dr Jaspreet Singh , Senior Research ... a speech at the 2015 Asian Starch Conference, to be ... Center.  , ... topic: ,Potato Starch: A Potential Source for the Creation ... Co-editor of a 528 page text book entitled "Advances ...
Breaking Biology Technology:Bone Biologics Corp Completes Financing With Hankey Capital, LLC 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 3Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2
... Pharmaceuticals wins the EFQM Excellence Awards 2011, the first ... by EFQM, the award recognizes business performance measured against ... Model. Another 9 organisations received Prizes for role model ... Excellence. 118 independent assessors visited 20 organisations ...
... and IPSWICH, Mass., Oct. 25, 2011 SwitchGear ... services for studying regulatory elements in the human genome, ... Inc. (NEB) to create a new dual reporter assay ... Luciferase Assay System and NEB,s BioLux® Cypridina ...
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ... today that its work entitled "Evaluation of the Safety ... Volunteers" will be presented at the Eleventh Annual Meeting ... San Francisco, California. "The selection of Oramed ...
Cached Biology Technology:1 Award Winner and 9 Prize Winners in the EFQM Business Excellence Awards 2SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System 2Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) 2
Goat polyclonal to Centaurin alpha 2**...
... background ,This solution greatly enhances antigen-antibody reactions, ... obtained with conventional methods. ,Two kinds of ... antibodies, which can suppress the background and ... versatility ,It is applicable to various assay ...
Monocarboxylate (lactate) transporter 2...
Mouse anti human pro-Relaxin-2...
Biology Products: